Skip to main content
OpenTrials

Clinical trial condition

Hemorrhagic Disorders

Explore clinical trials studying Hemorrhagic Disorders. Study availability and eligibility vary by location and protocol.

4,583 public trials 830 recruiting studies
Refine in advanced search Browse all conditions

Hemorrhagic Disorders trial results

Completed

Epoetin Alfa in Treating Anemia in Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Multiple Myeloma and Anemia Caused By Chemotherapy

NCT00003341

Conditions
Anemia, Blood Protein Disorders, Cardiovascular Diseases, +33 more
Locations
  • Alta Bates Comprehensive Cancer Center Berkeley, California, United States
  • USC/Norris Comprehensive Cancer Center and Hospital Los Angeles, California, United States
  • Jonsson Comprehensive Cancer Center, UCLA Los Angeles, California, United States
  • Comprehensive Cancer Centers of the Desert Palm Springs, California, United States
View all 18 locations
View Trial Details
Completed

Dolastatin 10 in Treating Patients With Indolent Lymphoma, Waldenstrom's Macroglobulinemia, or Chronic Lymphocytic Leukemia

NCT00005579

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +24 more
Locations
  • Marlene and Stewart Greenebaum Cancer Center, University of Maryland Baltimore, Maryland, United States
  • Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States
  • Arthur G. James Cancer Hospital - Ohio State University Columbus, Ohio, United States
  • Vermont Cancer Center Burlington, Vermont, United States
View Trial Details
Completed

Interferon Alfa Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Multiple Myeloma

NCT00003007

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • William F. Bowld Hospital Memphis, Tennessee, United States
  • Methodist Healthcare - Hospital of Memphis Memphis, Tennessee, United States
  • Baptist Memorial Hospital Memphis, Tennessee, United States
  • University of Tennessee, Memphis Memphis, Tennessee, United States
View Trial Details

Related conditions